Core Scientific, Inc. $CORZ Shares Purchased by Glenmede Trust Co. NA

Posted by George Bondi on Aug 8th, 2026

Glenmede Trust Co. NA increased its holdings in shares of Core Scientific, Inc. (NASDAQ:CORZ – Free Report) by 147.2% in the 1st quarter, HoldingsChannel reports. The firm owned 53,640 shares of the company’s stock after acquiring an additional 31,943 shares during the quarter. Glenmede Trust Co. NA’s holdings in Core Scientific were worth $802,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Xponance LLC boosted its holdings in Core Scientific by 2.5% during the fourth quarter. Xponance LLC now owns 22,896 shares of the company’s stock worth $333,000 after buying an additional 562 shares in the last quarter. Orion Porfolio Solutions LLC increased its holdings in Core Scientific by 5.2% in the third quarter. Orion Porfolio Solutions LLC now owns 15,539 shares of the company’s stock valued at $279,000 after buying an additional 766 shares in the last quarter. Bank of Montreal Can raised its position in shares of Core Scientific by 4.2% in the fourth quarter. Bank of Montreal Can now owns 21,592 shares of the company’s stock worth $314,000 after acquiring an additional 869 shares during the period. Allworth Financial LP raised its position in shares of Core Scientific by 206.5% in the third quarter. Allworth Financial LP now owns 1,410 shares of the company’s stock worth $25,000 after acquiring an additional 950 shares during the period. Finally, Pathstone Holdings LLC boosted its stake in shares of Core Scientific by 1.3% during the 3rd quarter. Pathstone Holdings LLC now owns 76,094 shares of the company’s stock worth $1,365,000 after acquiring an additional 967 shares in the last quarter.

Insider Transactions at Core Scientific

In other Core Scientific news, insider Todd M. Duchene sold 10,000 shares of the stock in a transaction dated Monday, August 3rd. The shares were sold at an average price of $22.23, for a total value of $222,300.00. Following the completion of the sale, the insider owned 1,979,101 shares in the company, valued at approximately $43,995,415.23. This represents a 0.50% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Over the last three months, insiders have sold 90,000 shares of company stock worth $2,248,600. 1.70% of the stock is currently owned by corporate insiders.

Core Scientific Stock Performance

NASDAQ CORZ opened at $21.01 on Friday. The business has a fifty day moving average price of $24.59 and a 200 day moving average price of $20.95. The company has a market cap of $6.75 billion, a P/E ratio of -4.75 and a beta of 5.59. Core Scientific, Inc. has a one year low of $13.14 and a one year high of $30.46.

Core Scientific (NASDAQ:CORZ – Get Free Report) last released its earnings results on Tuesday, July 28th. The company reported ($3.32) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.06) by ($3.26). The firm had revenue of $164.20 million for the quarter, compared to analyst estimates of $144.83 million. As a group, sell-side analysts predict that Core Scientific, Inc. will post -1.36 EPS for the current fiscal year.

Wall Street Analyst Weigh In

A number of equities research analysts have recently commented on the company. Keefe, Bruyette & Woods upgraded Core Scientific from a “market perform” rating to an “outperform” rating and lifted their price target for the company from $25.00 to $28.00 in a research note on Thursday, July 30th. Needham & Company LLC increased their price target on Core Scientific from $29.00 to $35.00 and gave the stock a “buy” rating in a research report on Wednesday, July 29th. Canaccord Genuity Group raised their price objective on Core Scientific from $30.00 to $36.00 and gave the company a “buy” rating in a report on Wednesday, July 29th. Weiss Ratings restated a “sell (d-)” rating on shares of Core Scientific in a research report on Friday, July 17th. Finally, Capital One Financial set a $33.00 target price on Core Scientific in a research report on Thursday, July 30th. Two equities research analysts have rated the stock with a Strong Buy rating, sixteen have issued a Buy rating, one has assigned a Hold rating and one has issued a Sell rating to the company. According to MarketBeat, Core Scientific currently has a consensus rating of “Moderate Buy” and an average price target of $32.18.

Get Our Latest Stock Analysis on Core Scientific

Core Scientific Profile

(Free Report)

Core Scientific, Inc (NASDAQ: CORZ) is a leading provider of large-scale blockchain infrastructure and digital asset mining services. The company develops, owns and operates high-performance data centers optimized for the mining of Bitcoin and other proof-of-work cryptocurrencies. In addition to its core mining operations, Core Scientific offers colocation, hosting and managed services designed to support institutional clients and enterprise users in deploying and scaling blockchain nodes and computing hardware.

Core Scientific’s service portfolio includes hardware procurement, deployment and maintenance, real-time monitoring, power management and network connectivity.